foxo4-dri peptide senolytic 2023 Frontiers The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI Averix Labs FOXO4 DRI Beverly Hills Rejuvenation Center FOXO4 DRI Peptide for Cellular Senescence and Anti Aging Research
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17



